Evidence map›Paper›PMID 37291775›Full record

Observational studyCurrent drug research reviews2024

Effect of COVID-19 Vaccination on Menstrual Cycle Patterns of Reproductive-age Women: A Multi-centric Observational Study.

Naina Kumar, Neha Gangane, Ipsita Mohapatra, Charushila Rukadikar, Vijayan Sharmila, K Pushpalatha, Madhavi Eerike, G Santhoshi, Subha Ranjan Samantaray, Shikha Seth and 6 more

Abstract readObservational StudyMulticenter Study
PubMed Publisher
In one paragraph

Observational study in Current drug research reviews, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Naina KumarDepartment of Obstetrics and Gynecology, All India Institute of Medical Sciences, Hyderabad, Telangana, India.
Neha GanganeDepartment of Obstetrics and Gynecology, All India Institute of Medical Sciences, Nagpur, Maharashtra, India.
Ipsita MohapatraDepartment of Obstetrics and Gynecology, All India Institute of Medical Sciences, Kalyani, West Bengal, India.
Charushila RukadikarDepartment of Physiology, All India Institute of Medical Sciences, Gorakhpur, Uttar Pradesh, India.
Vijayan SharmilaDepartment of Obstetrics and Gynecology, All India Institute of Medical Sciences, Mangalagiri, Andhra Pradesh, India.
K PushpalathaDepartment of Obstetrics and Gynecology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Madhavi EerikeDepartment of Pharmacology, All India Institute of Medical Sciences, Hyderabad, Telangana, India.
G SanthoshiDepartment of Obstetrics and Gynecology, All India Institute of Medical Sciences, Hyderabad, Telangana, India.
Subha Ranjan SamantarayDepartment of Obstetrics and Gynecology, All India Institute of Medical Sciences, Kalyani, West Bengal, India.
Shikha SethDepartment of Obstetrics and Gynecology, All India Institute of Medical Sciences, Gorakhpur, Uttar Pradesh, India.
Pragati TrigunaitDepartment of Obstetrics and Gynecology, All India Institute of Medical Sciences, Mangalagiri, Andhra Pradesh, India.
Nanditha Jangam ReddyDepartment of Obstetrics and Gynecology, All India Institute of Medical Sciences, Mangalagiri, Andhra Pradesh, India.
Shweta PatelDepartment of Obstetrics and Gynecology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Sandhya RaniDepartment of Obstetrics and Gynecology, All India Institute of Medical Sciences, Hyderabad, Telangana, India.
Roopanshi MishraDepartment of Physiology, All India Institute of Medical Sciences, Gorakhpur, Uttar Pradesh, India.
Kamlesh NegiDepartment of Physiology, All India Institute of Medical Sciences, Gorakhpur, Uttar Pradesh, India.
All India Institute of Medical Sciences · INAll India Institute of Medical Sciences Bhopal · INAll India Institute of Medical Sciences, Nagpur

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe study was conducted to know the impact of COVID-19 vaccination on menstrual cycle patterns and pre- and post-menstrual symptoms in women aged 18-45 years.

backgroundCOVID-19 vaccination was introduced to combat the dreadful impacts of human coronavirus infection. The two indigenously developed COVID-19 vaccines approved for use in India are COVISHIELD and COVAXIN.

objectivesTo investigate the effects of COVID-19 vaccination on the menstrual cycle, pre- and post-menstrual symptoms and to establish the correlation with the type of vaccine received.

methodsMulti-centric observational study conducted in six institutes of national importance in different states of India over one year. A total of 5709 female participants fulfilling inclusion criteria were enrolled. Data about the impact of vaccines (COVISHIELD and COVAXIN) and prior COVID-19 infection on the menstrual cycle and its associated symptoms were obtained using all participants' online and offline interviews.

resultsOf 5709 participants, 78.2% received COVISHIELD and 21.8% COVAXIN. Of the total 5709 participants, 333 (5.8%) developed post-vaccination menstrual disturbances, with 32.7% having frequent cycles, 63.7% prolonged cycles, and 3.6% inter-menstrual bleeding. A total of 301 participants noticed changes in the amount of bleeding, with 50.2% excessive, 48.8% scanty, and 0.99% amenorrhea followed by heavy bleeding. Furthermore, the irregularities of the menstrual cycle (p = 0.011) and length (0.001) were significantly higher in the COVAXIN group (7.2%) as compared to the COVISHIELD (5.3%) group. A total of 721 participants complained of newly developed/worsening pre- and post-menstrual symptoms. These symptoms were significantly higher in the COVISHIELD group (p = 0.031), with generalized weakness and body pains as the main complaints (p = 0.001). No significant difference was observed in the incidence of COVID-19 infection with these vaccines. No significant associations were observed when comparing menstrual abnormalities among those with COVID-19 infection (p > 0.05).

conclusionCOVISHIELD and COVAXIN vaccines were associated with menstrual cycle disturbances and pre-and post-menstrual symptoms in a small proportion of participants, with 94.7% having no change in the amount of bleeding during menstruation post-vaccination. The menstrual irregularities observed were significantly higher with the COVAXIN vaccine. Others: Further, long-term studies are required to confirm that the impact of COVID-19 vaccination on the menstrual cycle may be short-lasting, with no severe effects on women's menstrual health.

Indexed as

COVID-19COVID-19 VaccinesMenstrual CycleAdolescentAdultFemaleHumansIndiaMenstruation DisturbancesMiddle AgedSARS-CoV-2VaccinationYoung AdultCOVID-19 VaccinesCOVAXINCOVID-19COVISHIELDinfectionmenstrual cyclevaccination.

Identifiers

PMID37291775
OpenAlexW4379967768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.